MYCOSIS FUNGOIDES/SEZARY SYNDROME
Clinical trials for MYCOSIS FUNGOIDES/SEZARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MYCOSIS FUNGOIDES/SEZARY SYNDROME trials appear
Sign up with your email to follow new studies for MYCOSIS FUNGOIDES/SEZARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets rare skin cancer in small trial
Disease control OngoingThis study tests whether combining pembrolizumab (an immunotherapy) with gemcitabine (a chemotherapy drug) can shrink tumors in people with advanced mycosis fungoides or Sézary syndrome, rare types of skin lymphoma. The trial enrolled 14 adults who had already tried at least one …
Matched conditions: MYCOSIS FUNGOIDES/SEZARY SYNDROME
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New pill shows promise for rare skin cancer in early trial
Disease control OngoingThis early-phase trial tests a new drug called tulmimetostat (DZR123) in 24 people with advanced mycosis fungoides or Sézary syndrome, rare types of skin lymphoma. Participants must have tried at least one prior treatment. The study aims to see if the drug is safe and tolerable, …
Matched conditions: MYCOSIS FUNGOIDES/SEZARY SYNDROME
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC